Market Cap 2.07B
Revenue (ttm) 874.84M
Net Income (ttm) 263.86M
EPS (ttm) N/A
PE Ratio 5.72
Forward PE N/A
Profit Margin 30.16%
Debt to Equity Ratio -1.85
Volume 3,591,700
Avg Vol 3,717,418
Day's Range N/A - N/A
Shares Out 255.54M
Stochastic %K 3%
Beta 0.57
Analysts Strong Sell
Price Target $20.36

Company Profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat HAE. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 919 859 1302
Fax: 919 859 1314
Address:
4505 Emperor Boulevard, Suite 200, Durham, United States
gdesivir
gdesivir Sep. 13 at 1:21 PM
$BCRX Rather than worrying about competitor drugs, think about the impact once Navenibart is approved. 1. ~90%+ attack reduction 2. Strong Q6M efficacy 3. Clean safety/tolerability 4. Low injection-site reactions 5. Good patient preference/adherence 6. Ability to compete against Takhzyro and newer HAE prophylaxis products. navenibart itself could become a $1B+ peak annual product globally.
1 · Reply
TradingVolume
TradingVolume Sep. 13 at 1:00 PM
$BCRX Swinging both!
0 · Reply
Paulzk
Paulzk Sep. 13 at 9:29 AM
$BCRX Time to rethink our foreign aid. The United States has provided Israel a cumulative total of more than $300 billion (inflation-adjusted) in bilateral assistance and military funding since 1946, making it the largest cumulative recipient of U.S. foreign aid since World War II. Baseline Annual Rate (2019–2028): Under a 10-year Memorandum of Understanding (MOU) signed in 2016, the U.S. provides $3.8 billion per year ($3.3 billion in Foreign Military Financing and $500 million for cooperative missile defense).Post-October 7 Supplements: Between late 2023 and 2025, Congress enacted additional military packages providing over $16.3 billion in extra direct wartime assistance alongside the baseline annual funding.
0 · Reply
Paulzk
Paulzk Sep. 13 at 9:11 AM
$BCRX I would think oil prices will spike Monday. A closed Saudi pipeline and Houthi military advances. An Iranian commercial vessel attacked near Qeshm Island
0 · Reply
Paulzk
Paulzk Sep. 13 at 9:02 AM
$BCRX Way Cool ! Trending Watch 1 BCRX Biocryst Pharmaceuticals Inc.
1 · Reply
Paulzk
Paulzk Sep. 13 at 8:52 AM
$BCRX The inflationary effect on family will be very painful. Electricity cost will rise. Home, food and auto cost will rise. A modern car typically contains between 1,000 and 3,000 semiconductor chips, though high-end luxury or electric vehicles can have up to 3,500 chips. When you add up every major gadget, smart appliance, and hidden microcontroller, a standard household easily harbors several hundred (and sometimes over a thousand) individual semiconductor chips
0 · Reply
ducslayer
ducslayer Sep. 13 at 8:30 AM
$BCRX IRWD take 2 . Dog shite
1 · Reply
Paulzk
Paulzk Sep. 13 at 8:24 AM
$BCRX Google's enormous capital budget does not necessarily represent an enormous financial burden, despite producing negative free cash flow last quarter for the first time ever. If a server pays for itself in less than two years — and proprietary silicon pays back in roughly one year — Google can recycle that capital into the next generation of infrastructure much faster than a simple comparison of annual capex suggests. https://finance.yahoo.com/technology/ai/articles/google-just-dropped-bombshell-ai-185617741.html
0 · Reply
Paulzk
Paulzk Sep. 13 at 8:18 AM
$BCRX On June 25, Apple announced (4) price increases for Macs and iPads by hundreds of dollars. And Apple isn't alone. Other major device makers, including Hewlett-Packard (NYSE:HPQ), Dell (NYSE:DELL) and Nintendo, have already raised prices. The Wall Street Journal reported that prices for memory and storage chips have quadrupled since last year as demand surged.
0 · Reply
Paulzk
Paulzk Sep. 13 at 8:17 AM
$BCRX "Tim Cook, who told The Wall Street Journal that the jump in costs was unlike anything he had seen 'in any area in over 40 years,'" Musk wrote in a post on X, adding, "Biggest price jump in anything I've ever seen too" (2). Musk also shared a Wall Street Journal article titled, "The Data-Center Boom Is Sparking a Third Wave of Inflation" https://finance.yahoo.com/economy/articles/tim-cook-warns-us-crisis-111500350.html
0 · Reply
Latest News on BCRX
BioCryst to Present at Upcoming Investor Conference

Sep 1, 2026, 7:00 AM EDT - 12 days ago

BioCryst to Present at Upcoming Investor Conference


BioCryst announces Japan MHLW marketing approval for Orladeyo

2026-08-25T11:15:20.000Z - 19 days ago

BioCryst announces Japan MHLW marketing approval for Orladeyo


BioCryst price target lowered to $20 from $21 at Wedbush

2026-08-06T12:47:36.000Z - 5 weeks ago

BioCryst price target lowered to $20 from $21 at Wedbush


BioCryst price target lowered to $13 from $14 at RBC Capital

2026-08-06T10:46:51.000Z - 5 weeks ago

BioCryst price target lowered to $13 from $14 at RBC Capital


BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 5 weeks ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2026


BioCryst Pharmaceuticals Earnings release: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 5 weeks ago

BioCryst Pharmaceuticals Earnings release: Q2 2026


BioCryst Pharmaceuticals Slides: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 5 weeks ago

BioCryst Pharmaceuticals Slides: Q2 2026


BioCryst Pharmaceuticals Quarterly report: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 5 weeks ago

BioCryst Pharmaceuticals Quarterly report: Q2 2026


BioCryst Reports Second Quarter 2026 Financial Results

Aug 5, 2026, 7:00 AM EDT - 5 weeks ago

BioCryst Reports Second Quarter 2026 Financial Results


BioCryst appoints David Jenkins as chief scientific officer

2026-07-15T11:10:48.000Z - 2 months ago

BioCryst appoints David Jenkins as chief scientific officer


BioCryst Appoints David W. Jenkins as Chief Scientific Officer

Jul 15, 2026, 7:00 AM EDT - 2 months ago

BioCryst Appoints David W. Jenkins as Chief Scientific Officer


BioCryst resumed with a Neutral at JPMorgan

2026-07-13T09:50:32.000Z - 2 months ago

BioCryst resumed with a Neutral at JPMorgan


BioCryst price target raised to $14 from $13 at RBC Capital

2026-07-07T11:20:35.000Z - 2 months ago

BioCryst price target raised to $14 from $13 at RBC Capital


BioCryst to present new Orladeyo data at EAACI

2026-06-12T11:15:09.000Z - 3 months ago

BioCryst to present new Orladeyo data at EAACI


BioCryst price target raised to $28 from $25 at Citizens

2026-05-07T11:43:06.000Z - 4 months ago

BioCryst price target raised to $28 from $25 at Citizens


BioCryst reports Q1 EPS ($2.98), consensus 11c

2026-05-07T06:49:24.000Z - 4 months ago

BioCryst reports Q1 EPS ($2.98), consensus 11c


BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 4 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2026


BioCryst Pharmaceuticals Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 4 months ago

BioCryst Pharmaceuticals Earnings release: Q1 2026


BioCryst Pharmaceuticals Slides: Q1 2026

May 6, 2026, 8:30 AM EDT - 4 months ago

BioCryst Pharmaceuticals Slides: Q1 2026


BioCryst Pharmaceuticals Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 4 months ago

BioCryst Pharmaceuticals Quarterly report: Q1 2026


BioCryst to Present at Upcoming Investor Conferences

Apr 28, 2026, 7:00 AM EDT - 4 months ago

BioCryst to Present at Upcoming Investor Conferences


BioCryst Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

BioCryst Pharmaceuticals Proxy statement: Proxy filing


BioCryst Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

BioCryst Pharmaceuticals Proxy statement: Proxy filing


BioCryst to Report First Quarter 2026 Financial Results on May 6

Apr 15, 2026, 7:00 AM EDT - 5 months ago

BioCryst to Report First Quarter 2026 Financial Results on May 6


BioCryst price target raised to $14 from $13 at RBC Capital

2026-04-07T15:13:58.000Z - 5 months ago

BioCryst price target raised to $14 from $13 at RBC Capital


BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025


BioCryst Pharmaceuticals Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

BioCryst Pharmaceuticals Annual report: Q4 2025


BioCryst Pharmaceuticals Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

BioCryst Pharmaceuticals Earnings release: Q4 2025


BioCryst Pharmaceuticals Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

BioCryst Pharmaceuticals Slides: Q4 2025


BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2025


BioCryst Pharmaceuticals Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

BioCryst Pharmaceuticals Quarterly report: Q3 2025


BioCryst Pharmaceuticals Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

BioCryst Pharmaceuticals Earnings release: Q3 2025


BioCryst Pharmaceuticals Slides: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

BioCryst Pharmaceuticals Slides: Q3 2025


BioCryst Pharmaceuticals Transcript: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 11 months ago

BioCryst Pharmaceuticals Transcript: M&A Announcement


BioCryst Pharmaceuticals Press release: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 11 months ago

BioCryst Pharmaceuticals Press release: M&A Announcement


BioCryst Pharmaceuticals Slides: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 11 months ago

BioCryst Pharmaceuticals Slides: M&A Announcement


BioCryst to buy Astria Therapeutics in $700 million deal

Oct 14, 2025, 7:35 AM EDT - 11 months ago

BioCryst to buy Astria Therapeutics in $700 million deal

ATXS


BioCryst Announces Departure of Dr. Helen Thackray

Aug 11, 2025, 7:00 AM EDT - 1 year ago

BioCryst Announces Departure of Dr. Helen Thackray


BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2025


BioCryst Pharmaceuticals Quarterly report: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Quarterly report: Q2 2025


BioCryst Pharmaceuticals Earnings release: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q2 2025


BioCryst Pharmaceuticals Slides: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Slides: Q2 2025


BioCryst Pharmaceuticals Transcript: M&A Announcement

Jun 27, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Transcript: M&A Announcement


BioCryst Pharmaceuticals Press release: M&A Announcement

Jun 27, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Press release: M&A Announcement


ORLADEYO® (berotralstat) Approved in Colombia

Jun 13, 2025, 7:00 AM EDT - 1 year ago

ORLADEYO® (berotralstat) Approved in Colombia


BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2025


BioCryst Pharmaceuticals Quarterly report: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Quarterly report: Q1 2025


BioCryst Pharmaceuticals Earnings release: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q1 2025


BioCryst Pharmaceuticals Slides: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Slides: Q1 2025


gdesivir
gdesivir Sep. 13 at 1:21 PM
$BCRX Rather than worrying about competitor drugs, think about the impact once Navenibart is approved. 1. ~90%+ attack reduction 2. Strong Q6M efficacy 3. Clean safety/tolerability 4. Low injection-site reactions 5. Good patient preference/adherence 6. Ability to compete against Takhzyro and newer HAE prophylaxis products. navenibart itself could become a $1B+ peak annual product globally.
1 · Reply
TradingVolume
TradingVolume Sep. 13 at 1:00 PM
$BCRX Swinging both!
0 · Reply
Paulzk
Paulzk Sep. 13 at 9:29 AM
$BCRX Time to rethink our foreign aid. The United States has provided Israel a cumulative total of more than $300 billion (inflation-adjusted) in bilateral assistance and military funding since 1946, making it the largest cumulative recipient of U.S. foreign aid since World War II. Baseline Annual Rate (2019–2028): Under a 10-year Memorandum of Understanding (MOU) signed in 2016, the U.S. provides $3.8 billion per year ($3.3 billion in Foreign Military Financing and $500 million for cooperative missile defense).Post-October 7 Supplements: Between late 2023 and 2025, Congress enacted additional military packages providing over $16.3 billion in extra direct wartime assistance alongside the baseline annual funding.
0 · Reply
Paulzk
Paulzk Sep. 13 at 9:11 AM
$BCRX I would think oil prices will spike Monday. A closed Saudi pipeline and Houthi military advances. An Iranian commercial vessel attacked near Qeshm Island
0 · Reply
Paulzk
Paulzk Sep. 13 at 9:02 AM
$BCRX Way Cool ! Trending Watch 1 BCRX Biocryst Pharmaceuticals Inc.
1 · Reply
Paulzk
Paulzk Sep. 13 at 8:52 AM
$BCRX The inflationary effect on family will be very painful. Electricity cost will rise. Home, food and auto cost will rise. A modern car typically contains between 1,000 and 3,000 semiconductor chips, though high-end luxury or electric vehicles can have up to 3,500 chips. When you add up every major gadget, smart appliance, and hidden microcontroller, a standard household easily harbors several hundred (and sometimes over a thousand) individual semiconductor chips
0 · Reply
ducslayer
ducslayer Sep. 13 at 8:30 AM
$BCRX IRWD take 2 . Dog shite
1 · Reply
Paulzk
Paulzk Sep. 13 at 8:24 AM
$BCRX Google's enormous capital budget does not necessarily represent an enormous financial burden, despite producing negative free cash flow last quarter for the first time ever. If a server pays for itself in less than two years — and proprietary silicon pays back in roughly one year — Google can recycle that capital into the next generation of infrastructure much faster than a simple comparison of annual capex suggests. https://finance.yahoo.com/technology/ai/articles/google-just-dropped-bombshell-ai-185617741.html
0 · Reply
Paulzk
Paulzk Sep. 13 at 8:18 AM
$BCRX On June 25, Apple announced (4) price increases for Macs and iPads by hundreds of dollars. And Apple isn't alone. Other major device makers, including Hewlett-Packard (NYSE:HPQ), Dell (NYSE:DELL) and Nintendo, have already raised prices. The Wall Street Journal reported that prices for memory and storage chips have quadrupled since last year as demand surged.
0 · Reply
Paulzk
Paulzk Sep. 13 at 8:17 AM
$BCRX "Tim Cook, who told The Wall Street Journal that the jump in costs was unlike anything he had seen 'in any area in over 40 years,'" Musk wrote in a post on X, adding, "Biggest price jump in anything I've ever seen too" (2). Musk also shared a Wall Street Journal article titled, "The Data-Center Boom Is Sparking a Third Wave of Inflation" https://finance.yahoo.com/economy/articles/tim-cook-warns-us-crisis-111500350.html
0 · Reply
JPtheBCRXdestroyer1
JPtheBCRXdestroyer1 Sep. 13 at 4:15 AM
$BCRX When the Navenbart data is not statistically significant at 3 month against placebo 1s will come hard and fast.
0 · Reply
1point21gigawatts
1point21gigawatts Sep. 12 at 7:10 PM
$BCRX following trend line from early 2020 at this point. Nice place to add.
0 · Reply
Paulzk
Paulzk Sep. 12 at 12:23 PM
$BCRX Yemen 's Iranian-backed Houthi rebels captured the island of Mayun at the entrance of the Red Sea, a key alternative for shipping Saudi oil and other exports since Iran has been targeting vessels in the Strait of Hormuz.
2 · Reply
Paulzk
Paulzk Sep. 12 at 12:19 PM
$BCRX A BCRX investor waiting for an embarrassment of riches.
0 · Reply
Paulzk
Paulzk Sep. 12 at 12:16 PM
$BCRX XBI's 5 year performance verses S&P.
0 · Reply
Paulzk
Paulzk Sep. 12 at 12:12 PM
$BCRX Saudi Arabia said Friday that it shut down the kingdom’s crucial East-West crude oil pipeline as a precautionary measure after multiple attacks by drones launched from Iraq. The Saudis have relied on the East-West pipeline to shift crude oil exports away from Persian Gulf as the U.S. and Iran battle for control over the Strait of Hormuz. Oil prices closed out the week more than 8% higher.
1 · Reply
Paulzk
Paulzk Sep. 12 at 8:09 AM
$BCRX Just another week at BCRX
0 · Reply
Paulzk
Paulzk Sep. 12 at 8:02 AM
$BCRX What has BCRX management done for investors. 5 year returns S&P verses BCRX.
1 · Reply
smnorgy
smnorgy Sep. 12 at 2:09 AM
$BCRX Tak. Will buy us for 15
3 · Reply
JPtheBCRXdestroyer1
JPtheBCRXdestroyer1 Sep. 12 at 1:07 AM
$BCRX oh wow I didnt even know this piece of shit flushed lol. Its such a foregone conclusion at this point I only pay attention to it in hopes that I can rescue a long here from themselves. I know, as Yuri Bezmemov has said about useful idiots, the longs here are demoralized and at this point you could tell them white is white and black is black and they wouldn't believe you. But I hope to save one before this goes to pennies.
1 · Reply
et1000
et1000 Sep. 11 at 11:47 PM
Ticker MLEC is the next nano float runner ! Every small float ticker has been running almost 500% recently Would not be surprised if they send MLEC up next. MLEC starting to make its move now! Only 573k shares outstanding! 💎 $BRK.B $CIFR $RDDT $BCRX spa
1 · Reply
BigGainTom
BigGainTom Sep. 11 at 8:51 PM
$BCRX purely a "rising tide" stock. Never goes up on its own.
1 · Reply